Leveraging ctDNA Analysis to Improve Early Detection of Cancer Recurrence in the High-Risk Melanoma Setting

Clinical trial NCT05079113 · COMPLETED

Trial details

NCT number: NCT05079113
Sponsor: Case Comprehensive Cancer Center
Status: COMPLETED
Study type: OBSERVATIONAL

Stage III Melanoma Stage IV Cutaneous Melanoma

Start date: 2019-10-01
Primary completion: 2023-04-04
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.